Calcium-binding proteins and calcium-dependent signaling proteins (CaBPs)

Calcium-binding proteins (CaBPs) and calcium-dependent signaling proteins are a vast group of molecules that translate intracellular calcium (Ca2+) fluctuations into specific biological responses. These proteins typically contain specialized domains, such as the EF-hand motif, which allow them to sense and bind Ca2+ with high affinity and specificity (Source: UniProt, "Calcium-binding protein"). Upon binding, they undergo conformational changes that enable interactions with a wide array of target proteins, including enzymes like calcineurin and various ion channels, thereby regulating processes such as muscle contraction, gene expression, and apoptosis (Source: PubMed, PMID: 21358975). In clinical contexts, dysregulation of CaBPs is linked to diseases ranging from cardiomyopathy to Alzheimer's disease and cancer (Source: NIH, "Calcium Signaling in Disease"). Therapeutic strategies often involve modulating these proteins to restore calcium homeostasis or block pathological signaling pathways. For example, drugs like levosimendan increase the calcium sensitivity of troponin C to treat heart failure, while others target S100 proteins to manage inflammation (Source: StatPearls, "Calcium Channel Blockers"). However, the ubiquitous nature of calcium signaling presents significant challenges for drug specificity and safety (Source: PubMed, PMID: 29107551).

Other names

Calcium-binding proteinsCalcium sensorsEF-hand proteinsCalcium-modulated proteinsCaBPs

Drugs targeting these proteins typically act by modulating calcium sensitivity, inhibiting calcium-dependent protein-protein interactions, or stabilizing specific conformational states to alter downstream signaling (Source: PubMed, PMID: 21358975).